CMS Medicare GLP-1 Bridge final rule, 2026 Humana is the CMS-selected central processor for the Medicare GLP-1 Bridge program, which offers eligible beneficiaries Wegovy for weight loss at $50 per month through December 31, 2027
This work was supported by the Funds of the National Natural Science Foundation of China (82060728), the Guizhou Provincial Science and Technology Department (MS [2025-380], Thousand Talents Program), the Talents of Guizhou Science and Technology Platform [2021]1350-009, the Zunyi Science and Technology Bureau (HZ-2023-173, HZ-2023-09, [2024] No
Mild headache : Occasionally reported in clinical studies, typically transient
Original (7280 pixels wide) Large (2400 pixels wide) Medium (1920 pixels wide) Small (640 pixels wide) Reimagine This Image Bookmark icon Collection Similar icon Similar Share icon Share Checkmark icon Pro Standard License What's This
Since gastrointestinal adverse effects are rarely severe and tend to diminish over time, they would therefore not be expected to cause a barrier to initiating and continuing treatment for most patients
However, analysts noted the benefit was primarily driven by reductions in nonfatal myocardial infarctions, with no significant impact on cardiovascular death or stroke
